drug protocol number

GA45331

drug sponsor

Roche / IQVIA

drug study

Ro7790121

drug trial site

King Faisal Specialist Hospital and Research Center (Riyadh), King Saud Medical City (Riyadh)

drug status

Ongoing

drug phase